N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)

C102H110Cl2N20O8 — CID 158848813

IUPACN-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)
SMILESCc1cccc(CNC(=O)c2nn(CCO)c3c2CN(Cc2c[nH]c4ccccc24)CC3)c1.Cc1cccc(CNC(=O)c2nn(CCO)c3c2CN(Cc2c[nH]c4ccccc24)CC3)c1.O=C(NCc1ccc(Cl)cc1)c1nn(CCO)c2c1CN(Cc1c[nH]c3ccccc13)CC2.O=C(NCc1cccc(Cl)c1)c1nn(CCO)c2c1CN(Cc1c[nH]c3ccccc13)CC2
InChIInChI=1S/2C26H29N5O2.2C25H26ClN5O2/c2*1-18-5-4-6-19(13-18)14-28-26(33)25-22-17-30(10-9-24(22)31(29-25)11-12-32)16-20-15-27-23-8-3-2-7-21(20)23;26-19-5-3-4-17(12-19)13-28-25(33)24-21-16-30(9-8-23(21)31(29-24)10-11-32)15-18-14-27-22-7-2-1-6-20(18)22;26-19-7-5-17(6-8-19)13-28-25(33)24-21-16-30(10-9-23(21)31(29-24)11-12-32)15-18-14-27-22-4-2-1-3-20(18)22/h2*2-8,13,15,27,32H,9-12,14,16-17H2,1H3,(H,28,33);1-7,12,14,27,32H,8-11,13,15-16H2,(H,28,33);1-8,14,27,32H,9-13,15-16H2,(H,28,33)
InChIKeyIZEICUWKWOHUHO-UHFFFAOYSA-N
MW1815.04 g/mol
LogP13.30
Rot. Bonds28

About N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)

N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide) (PubChem CID 158848813) has the molecular formula C102H110Cl2N20O8 and a molecular weight of 1815.04 g/mol. Its IUPAC name is N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide).

Molecular Properties

Compound NameN-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)
PubChem CID158848813
Molecular FormulaC102H110Cl2N20O8
Molecular Weight1815.04 g/mol
Exact Mass1812.82
IUPAC NameN-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)
SMILESCc1cccc(CNC(=O)c2nn(CCO)c3c2CN(Cc2c[nH]c4ccccc24)CC3)c1.Cc1cccc(CNC(=O)c2nn(CCO)c3c2CN(Cc2c[nH]c4ccccc24)CC3)c1.O=C(NCc1ccc(Cl)cc1)c1nn(CCO)c2c1CN(Cc1c[nH]c3ccccc13)CC2.O=C(NCc1cccc(Cl)c1)c1nn(CCO)c2c1CN(Cc1c[nH]c3ccccc13)CC2
InChIInChI=1S/2C26H29N5O2.2C25H26ClN5O2/c2*1-18-5-4-6-19(13-18)14-28-26(33)25-22-17-30(10-9-24(22)31(29-25)11-12-32)16-20-15-27-23-8-3-2-7-21(20)23;26-19-5-3-4-17(12-19)13-28-25(33)24-21-16-30(9-8-23(21)31(29-24)10-11-32)15-18-14-27-22-7-2-1-6-20(18)22;26-19-7-5-17(6-8-19)13-28-25(33)24-21-16-30(10-9-23(21)31(29-24)11-12-32)15-18-14-27-22-4-2-1-3-20(18)22/h2*2-8,13,15,27,32H,9-12,14,16-17H2,1H3,(H,28,33);1-7,12,14,27,32H,8-11,13,15-16H2,(H,28,33);1-8,14,27,32H,9-13,15-16H2,(H,28,33)
InChIKeyIZEICUWKWOHUHO-UHFFFAOYSA-N
XLogP13.30
TPSA344.72 Ų
H-Bond Donors12
H-Bond Acceptors20
Rotatable Bonds28
Heavy Atoms132
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001815.04
LogP ≤ 513.30
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1020

Analyze N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)?
The IUPAC name of N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide) (CID 158848813) is N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide).
What is the SMILES notation for N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)?
The canonical SMILES for N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide) is Cc1cccc(CNC(=O)c2nn(CCO)c3c2CN(Cc2c[nH]c4ccccc24)CC3)c1.Cc1cccc(CNC(=O)c2nn(CCO)c3c2CN(Cc2c[nH]c4ccccc24)CC3)c1.O=C(NCc1ccc(Cl)cc1)c1nn(CCO)c2c1CN(Cc1c[nH]c3ccccc13)CC2.O=C(NCc1cccc(Cl)c1)c1nn(CCO)c2c1CN(Cc1c[nH]c3ccccc13)CC2.
What is the InChIKey of N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)?
The InChIKey is IZEICUWKWOHUHO-UHFFFAOYSA-N. The full InChI is InChI=1S/2C26H29N5O2.2C25H26ClN5O2/c2*1-18-5-4-6-19(13-18)14-28-26(33)25-22-17-30(10-9-24(22)31(29-25)11-12-32)16-20-15-27-23-8-3-2-7-21(20)23;26-19-5-3-4-17(12-19)13-28-25(33)24-21-16-30(9-8-23(21)31(29-24)10-11-32)15-18-14-27-22-7-2-1-6-20(18)22;26-19-7-5-17(6-8-19)13-28-25(33)24-21-16-30(10-9-23(21)31(29-24)11-12-32)15-18-14-27-22-4-2-1-3-20(18)22/h2*2-8,13,15,27,32H,9-12,14,16-17H2,1H3,(H,28,33);1-7,12,14,27,32H,8-11,13,15-16H2,(H,28,33);1-8,14,27,32H,9-13,15-16H2,(H,28,33).
What are the key properties of N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide)?
N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide) has a molecular weight of 1815.04 g/mol, XLogP of 13.30, 28 rotatable bonds, 12 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;N-[(4-chlorophenyl)methyl]-1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide;bis(1-(2-hydroxyethyl)-5-(1H-indol-3-ylmethyl)-N-[(3-methylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide) is sourced from PubChem (CID 158848813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).